Abstract:Alzheimer′s disease (AD) is a complex neurodegenerative disorder of the central nervous system. Increasing evidence indicates that copper metabolism plays a critical role in its pathogenesis. Copper exerts dual functions in maintaining neuronal activity and redox homeostasis, while its dysregulation may accelerate AD progression by promoting amyloid β-protein (Aβ) aggregation, tau hyperphosphorylation, oxidative stress, and neuroinflammation. In recent years, a newly recognized form of programmed cell death, known as “cuproptosis”, has also been implicated in the neuropathological processes of AD. In this article, we review the physiological mechanisms of copper metabolism and its interactions with Aβ, tau, apolipoprotein E, and other pathogenic factors in AD, with a focus on potential therapeutic strategies targeting copper homeostasis, aiming to provide novel insights into early diagnosis and precise intervention for AD.